Michael Wilcox
Psychiatry · Charleston, SCNPI 1891892683
Payments from drug & device makers
Across 928 payments — averaging $12.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Vanda Pharmaceuticals Inc.$2K
- Sunovion Pharmaceuticals Inc.$1K
- Lundbeck LLC$1K
- Corium, LLC$1K
- Otsuka America Pharmaceutical, Inc.$995
- plus $3K from 13 others
What the payments were for
- Food & beverage$11,33299%
- Education$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 231 | $1,996 |
| Vanda Pharmaceuticals Inc. | 66 | $1,549 |
| Sunovion Pharmaceuticals Inc. | 128 | $1,365 |
| Lundbeck LLC | 82 | $1,212 |
| Corium, LLC | 87 | $1,085 |
| Otsuka America Pharmaceutical, Inc. | 64 | $995 |
| Axsome Therapeutics, Inc. | 50 | $769 |
| Neos Therapeutics, LP | 80 | $700 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 60 | $659 |
| E.r. Squibb & Sons, L.L.C. | 27 | $306 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $188 |
| Ironshore Pharmaceuticals Inc. | 12 | $143 |
| Tris Pharma Inc | 7 | $132 |
| Noven Therapeutics, LLC | 7 | $108 |
| Shire North American Group Inc | 6 | $91 |
| Eisai Inc. | 4 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $18 |
| Johnson & Johnson | 1 | $14 |
| Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fanapt$351
How this compares
$11,392 in reported general payments places this provider in the 90th percentile of 624 psychiatry providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 11 | $85,138 |
| VraylarCariprazine Hcl | 38 | $75,431 |
| CaplytaLumateperone Tosylate | 22 | $39,502 |
| RexultiBrexpiprazole | 18 | $34,078 |
| AuvelityDextromethorphan Hbr/Bupropion | 21 | $22,088 |
| Aripiprazole | 62 | $10,919 |
| VyvanseLisdexamfetamine Dimesylate | 13 | $4,984 |
| TrintellixVortioxetine Hydrobromide | 11 | $4,980 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 123 | $4,101 |
| Vilazodone Hcl | 39 | $3,515 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 30 | $2,787 |
| Bupropion XlBupropion Hcl | 74 | $2,361 |
| Duloxetine Hcl | 102 | $1,771 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $1,644 |
| Modafinil | 13 | $1,569 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,996 | $75,43138 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $659 | $39,50222 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $995 | $34,07818 claims |
| Axsome Therapeutics, Inc.Auvelity | $769 | $22,08821 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix | $188 | $9,96524 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 624 psychiatry providers in South Carolina.
Other psychiatry in Charleston
- Jacobo MintzerCharleston$4.9M
- Eduardo CifuentesCharleston$675K
- Mark GeorgeCharleston$332K
- Ricardo FermoCharleston$262K
- Thomas UhdeCharleston$205K
- Olga Brawman-MintzerCharleston$160K
- Jessica BroadwayCharleston$146K
- Floyd SalleeCharleston$121K
- Kathleen BradyCharleston$110K
- Constance GuilleCharleston$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.